Urgent suspicion of cancer referral

Lump
  • Any new discrete lump in patients 30 years and over
  • New asymmetrical nodularity that persists at review after two to three weeks (in patients over 35 years)
  • Unilateral isolated axillary lymph node in women persisting at review after two to three weeks
  • Recurrent lump at the site of a previously aspirated cyst
Nipple symptoms
  • Visibly bloodstained discharge
  • New unilateral nipple retraction
  • Nipple eczema if unresponsive to moderately potent topical steroids after a minimum of two weeks
Skin changes
  • Skin tethering
  • Fixation
  • Ulceration
  • Peau d’orange
Abscess/infection
  • Mastitis or breast inflammation which does not settle or recurs after one course of antibiotics

 

Good practice points

  Routine referral Primary care management - issue relevant advice leaflet (if available)
Lump
  • Any new discrete lump in patients under 30 years with no other suspicious features
  • New asymmetrical nodularity that persists at review after two to three weeks (in patients under 35 years)
  • Women with longstanding tender lumpy breasts and no focal lesion
  • Tender developing breasts in adolescents
Nipple Symptoms
  • Persistent unilateral spontaneous discharge sufficient to stain outer clothes
  • Transient nipple discharge which is not bloodstained
  • Check prolactin levels in persistent bilateral discharge
  • Longstanding nipple retraction
  • Nipple eczema if eczema present elsewhere
Skin changes  
  • Obvious simple skin lesions such as epidermoid (sebaceous) cysts
Abscess/infection  
  • Abscess or inflammation - try one course of antibiotics as per local guidelines
  • Any acute abscess requires immediate discussion with secondary care
Breast pain
  • Unilateral pain persisting over three months in post-menopausal women
  • Intractable pain that interferes with the person’s lifestyle or sleep
  • Women with moderate degrees of breast pain and no discrete palpable lesion
Gynaecomastia
  • Exceptional aesthetics referral to plastic surgery
    pathway if appropriate (i.e. NOT to the breast service)
  • Exclude or treat any endocrine cause prior to referral
  • Examine and exclude abnormalities such as lymphadenopathy or evidence of endocrine condition with blood tests as per local guidelines.
  • Review to exclude drug causes
Breast implants
  • If appropriate, refer to the service that first inserted the implant (usually plastic surgery)
  • Reassurance is often appropriate if symptoms relate to the implant alone and not to underlying breast tissue

 For genetics queries, please refer to regional guidance (see Appendix 5).

Full Guideline